FindTrial
Sign In

A Prospective Randomized Controlled Trial for Novel Femoral Neck System in the Treatment of Femoral Neck Fractures

A Prospective Randomized Controlled Trial for Novel Femoral Neck System in the Treatment of Femoral Neck Fractures

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029296
Enrollment
Unknown
Registered
2020-01-22
Start date
2020-01-22
Completion date
Unknown
Last updated
2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

femoral neck fracture

Interventions

Experimental group:new femoral neck system
Control group:three cannulated screw internal fixation

Sponsors

Department of orthopedic trauma, Luhe hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. displaced femoral neck fractures that are diagnosed by CT and X-ray; 2. aged >18 years old; 3. males or females; 4. have a history of injury.

Exclusion criteria

Exclusion criteria: 1. pathological fractures; 2. fracture with tumor or immunodeficiency disease; 3. fracture with spinal cord injury or nerve injury; 4. refuse to sign Informed consent.

Design outcomes

Primary

MeasureTime frame
Fracture healing time;Harris hip score;Vas score;nonunion;the incidence of adverse reactions after surgery;—

Secondary

MeasureTime frame
time of fully weight bearing;the length of Femoral neck;Neck angle;—

Countries

China

Contacts

Public ContactZhang Yakui

Beijing Luhe Hospital Affiliated to Capital Medical University

fulongzhao-doctor@163.com+86 13682561766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026